Low Level Lazer Therapy Effect on Vertebral Artery Blood Flow in Elderly With Cervical Disc Degeneration

Disc Degeneration Clinical Trial

Official title:

Low Level Lazer Therapy Effect on Vertebral Artery Blood Flow in Elderly With Cervical Disc Degeneration

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06025175
• Other study ID #: P.T_int_08/2023_519
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 15, 2023
• Est. completion date: January 1, 2024

Study information

• Verified date: September 2023
• Source: South Valley University
• Contact: Shymaa Y Abo zaid
• Phone: 01010941685
• Email: shaymaayoussef397[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will include 60 elderly patients with cervical disc degeneration, from both gender who are aged from 60 - 75 years old.

Description:

The 60 patients will divided into two groups, with 30 patients in each group. group(A): will receive low level lazer and exercises for three times per week for 12 weeks. Group (B): will receive only exercises. Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: January 1, 2024
• Est. primary completion date: October 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years to 75 Years

Eligibility

Inclusion Criteria:

1. elderly patients with age range between 60 and 75 years old.

2. with cervical disc degeneration.

Exclusion Criteria:

1. patients with uncontrolled hypertension.

2. Patients with uncontrolled diabetes mellitus.

3. Patients with severe cardiac or chest diseases.

Related Conditions & MeSH terms

• Disc Degeneration
• Intervertebral Disc Degeneration

Intervention

Radiation:
• Low level Lazer therapy
30 patients will receive low level lazer therapy 3 times a week for 12 weeks.

Other:
• Routine exercises
30 patients will receive only routine exercises 3 times a week for 12 weeks.

Locations

Country	Name	City	State
Egypt	Shymaa yussuf abo zaid	Qina

Sponsors (1)

Lead Sponsor	Collaborator
South Valley University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Resistivity index of both right and left vertebral arteries	Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.	12 weeks